Skip to content
Antimicrobial resistance (AMR) presents a clear threat to human health and healthcare systems. And in the post-COVID era, the threat and calls to address […]
AMR infections increased 20% during COVID-19 – and continue to pose a threat Read More »
July has turned out to be a good month for the fight against Alzheimer’s, with the approval of a new plaque-reducing drug and a
Kisunla approval and proposed CMS change signal progress against Alzheimer’s Read More »
The global rate of childhood vaccination “stalled in 2023,” the World Health Organization (WHO) says. Figures released July 15 show 2.7 million more children
Global child vaccination ‘stalled,’ still below pre-pandemic levels, WHO says Read More »
2001 was the dawn of the modern era of biosecurity in the United States. Following the 9/11 attacks and deadly anthrax letters, the nation
The House Ways and Means Committee learned how lawmakers can enable progress in biotech from a Biotechnology Innovation Organization (BIO) Board member and the
BIO Board member and head of BioUtah testify at House field hearing Read More »
The Federal Trade Commission (FTC) released an interim report on July 9 criticizing the negative impact pharmacy benefit managers (PBMs) have on prescription drug
FTC releases interim report criticizing PBMs Read More »
A few topics keep popping up in discussions about the future of U.S. healthcare over the past couple of years. The need to pass
3 key priorities shaping the future of U.S. healthcare and biotech Read More »
Microbial ecology and its potential applications are gaining prominence in biotechnology and healthcare. Cambridge-based Concerto Biosciences is helping drive advances in this area with
NIH Innovation Zone 2024: Concerto Biosciences illuminates collaboration of microbes Read More »
Biopharma Boehringer Ingelheim took a big step toward achieving the company’s goal of carbon neutrality by 2030 with the July 8 inauguration of a
Boehringer Ingelheim biomass plant cuts drug maker’s carbon footprint Read More »
Immuto Scientific is opening new frontiers in the fight against cancer by developing precision biotherapeutics that target highly cancer-specific surface protein conformations. Their ultimate
NIH Innovation Zone 2024: Immuto Scientific identifies new cancer targets Read More »
